PMID- 14622987 OWN - NLM STAT- MEDLINE DCOM- 20040213 LR - 20191210 IS - 0003-9861 (Print) IS - 0003-9861 (Linking) VI - 420 IP - 1 DP - 2003 Dec 1 TI - Measurement of oxygen consumption in mouse aortic endothelial cells using a microparticulate oximetry probe. PG - 169-75 AB - The purpose of this study was to determine the rate of oxygen consumption in mouse aortic endothelial cells (MAECs) and to determine the effect of a variety of inhibitors and stimulators of oxygen consumption measured by electron paramagnetic resonance (EPR) spectroscopy utilizing a new particulate oximetry probe. We have previously demonstrated that the octa-n-butoxy derivative of naphthalocyanine neutral radical (LiNc-BuO) enables accurate, precise, and reproducible measurements of pO(2) in cellular suspensions. In the current study, we carried out measurements to provide an accurate determination of pO(2) in small volume with less number of cells (20,000 cells) that has not been possible with other techniques. To establish the reliability of this method, agents such as menadione, lipopolysaccharide (LPS), potassium cyanide, rotenone, and diphenyleneiodonium chloride (DPI) were used to modulate the oxygen consumption rate in the cells. We observed an increase in oxygen consumption by the cells upon treatment with menadione and LPS, whereas treatment with cyanide, rotenone, and DPI inhibited oxygen consumption. This study clearly demonstrated the utilization of EPR spectrometry with LiNc-BuO probe for determination of oxygen concentration in cultured cells. FAU - Pandian, Ramasamy P AU - Pandian RP AD - Department of Internal Medicine, Center for Biomedical EPR Spectroscopy and Imaging, Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH 43210, USA. FAU - Kutala, Vijay Kumar AU - Kutala VK FAU - Parinandi, Narasimham L AU - Parinandi NL FAU - Zweier, Jay L AU - Zweier JL FAU - Kuppusamy, Periannan AU - Kuppusamy P LA - eng GR - R01 EB000890/EB/NIBIB NIH HHS/United States GR - R01 EB000890-04/EB/NIBIB NIH HHS/United States GR - CA 78886/CA/NCI NIH HHS/United States PT - Comparative Study PT - Evaluation Study PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PT - Validation Study PL - United States TA - Arch Biochem Biophys JT - Archives of biochemistry and biophysics JID - 0372430 RN - 0 (Lipopolysaccharides) RN - 0 (Metalloporphyrins) RN - 0 (Molecular Probes) RN - 0 (lithium 5,9,14,18,23,27,32,36-octa-n-butoxy-2,3-naphthocyanine) RN - 723JX6CXY5 (Vitamin K 3) RN - S88TT14065 (Oxygen) SB - IM MH - Animals MH - Aorta/drug effects/metabolism MH - Cell Respiration/physiology MH - Dose-Response Relationship, Drug MH - Electron Spin Resonance Spectroscopy/*instrumentation/methods MH - Endothelium, Vascular/drug effects/*metabolism MH - Equipment Design MH - Equipment Failure Analysis MH - Lipopolysaccharides/pharmacology MH - *Metalloporphyrins MH - Mice MH - Microchemistry/*instrumentation/methods MH - Molecular Probes MH - Oximetry/*instrumentation/methods MH - Oxygen/*analysis/*metabolism MH - Oxygen Consumption/drug effects/*physiology MH - Sensitivity and Specificity MH - Vitamin K 3/pharmacology EDAT- 2003/11/19 05:00 MHDA- 2004/02/14 05:00 CRDT- 2003/11/19 05:00 PHST- 2003/11/19 05:00 [pubmed] PHST- 2004/02/14 05:00 [medline] PHST- 2003/11/19 05:00 [entrez] AID - S0003986103004764 [pii] AID - 10.1016/j.abb.2003.09.008 [doi] PST - ppublish SO - Arch Biochem Biophys. 2003 Dec 1;420(1):169-75. doi: 10.1016/j.abb.2003.09.008.